Literature DB >> 16206334

Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?

John M Davis, Hilal Maradit-Kremers, Sherine E Gabriel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16206334

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  10 in total

1.  Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.

Authors:  Inge A M van den Oever; Alper M van Sijl; Michael T Nurmohamed
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

Review 2.  The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.

Authors:  Hilal Maradit Kremers; Elena Myasoedova; Cynthia S Crowson; Guergana Savova; Sherine E Gabriel; Eric L Matteson
Journal:  Rheumatology (Oxford)       Date:  2010-07-13       Impact factor: 7.580

Review 3.  Rheumatoid arthritis and the heart.

Authors:  Hilal Maradit Kremers; Sherine E Gabriel
Journal:  Curr Heart Fail Rep       Date:  2006-06

4.  Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic Drugs.

Authors:  Mary Chester Wasko; Abhijit Dasgupta; Genevieve Ilse Sears; James F Fries; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-05       Impact factor: 4.794

Review 5.  Atherosclerotic vascular disease in the autoimmune rheumatologic woman.

Authors:  Reto Daniel Kurmann; Rekha Mankad
Journal:  Clin Cardiol       Date:  2018-02-26       Impact factor: 2.882

Review 6.  Why do people with rheumatoid arthritis still die prematurely?

Authors:  S E Gabriel
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

Review 7.  Atherosclerosis and inflammation: insights from rheumatoid arthritis.

Authors:  Cecilia P Chung; Ingrid Avalos; Paolo Raggi; C Michael Stein
Journal:  Clin Rheumatol       Date:  2007-02-02       Impact factor: 3.650

8.  Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.

Authors:  Lena Innala; Bozena Möller; Lotta Ljung; Staffan Magnusson; Torgny Smedby; Anna Södergren; Marie-Louise Öhman; Solbritt Rantapää-Dahlqvist; Solveig Wållberg-Jonsson
Journal:  Arthritis Res Ther       Date:  2011-08-15       Impact factor: 5.156

9.  Possible Modulation of Vascular Function Measures in Rheumatoid Arthritis by Homocysteine.

Authors:  Mahmoud A Alomari; Omar F Khabour; Khaldoon Alawneh; Rania A Shammaa
Journal:  Int J Rheumatol       Date:  2018-07-02

Review 10.  Cardiovascular co-morbidity in rheumatic diseases.

Authors:  Carl Turesson; Lennart T H Jacobsson; Eric L Matteson
Journal:  Vasc Health Risk Manag       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.